Works about ALENDRONATE

Results: 908

Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide.

Published in:

Journal of Bone & Mineral Research, 2025, v. 40, n. 6, p. 773, doi. 10.1093/jbmr/zjaf053

By:

Cosman, Felicia;
Mitlak, Bruce H;
Wang, Yamei;
Pearman, Leny;
Moreira, Carolina A;
Lewiecki, E Michael;
Cummings, Steven R

Publication type:

Article

Extensive Maxillary Defect and Oroantral Fistula Resulting From Medication‐Induced Osteonecrosis in a Patient Undergoing Oral Surgery.

Published in:

Oral Surgery (1752-2471), 2025, v. 18, n. 3, p. 324, doi. 10.1111/ors.12963

By:

Marenucci, Naellen Rampazzo;
Sandoval, Lara Gabriela Da Silva Barbosa;
Costa, Bruna da Silva;
Rodrigues, Kathiussa Fernanda Parreira;
Bachesk, Andressa Bolognesi

Publication type:

Article

Formulation and Characterization of Bone-Targeting Vancomycin-Loaded Liposomes.

Published in:

Pharmaceutics, 2025, v. 17, n. 6, p. 792, doi. 10.3390/pharmaceutics17060792

By:

Karzoun, Basel;
Albenayan, Wala'a;
Raut, Shilpa;
Atef, Eman

Publication type:

Article

Distal Radius Fractures as a Call to Action: Reducing Subsequent Fragility Fracture Risk Through Early Osteoporosis Therapy.

Published in:

Geriatric Orthopaedic Surgery & Rehabilitation, 2025, p. 1, doi. 10.1177/21514593251351180

By:

Armando, Chenée;
Fox, Edward J.;
Taylor, Kenneth F.

Publication type:

Article

Editorial Expression of Concern: Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.

Published in:

2021

By:

Iwamoto, Jun;
Uzawa, Mitsuyoshi

Publication type:

Correction Notice

Retraction Note: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 8, p. 3385, doi. 10.1007/s10067-021-05788-3

By:

Iwamoto, Jun;
Takeda, Tsuyoshi;
Sato, Yoshihiro;
Uzawa, Mitsuyoshi

Publication type:

Article

Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 1, p. 205, doi. 10.1007/s10067-014-2812-y

By:

Iwamoto, Jun;
Uzawa, Mitsuyoshi

Publication type:

Article

Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.

Published in:

Clinical Rheumatology, 2015, v. 34, n. 4, p. 807, doi. 10.1007/s10067-014-2556-8

By:

Lopalco, Giuseppe;
Rigante, Donato;
Vitale, Antonio;
Frediani, Bruno;
Iannone, Florenzo;
Cantarini, Luca

Publication type:

Article

Alendronate treatment for hip osteoarthritis: prospective randomized 2-year trial.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 12, p. 1759, doi. 10.1007/s10067-013-2338-8

By:

Nishii, Takashi;
Tamura, Satoru;
Shiomi, Toshiyuki;
Yoshikawa, Hideki;
Sugano, Nobuhiko

Publication type:

Article

Nephrotic syndrome following hepatitis B vaccination: A 17-year follow-up.

Published in:

Northern Clinics of Istanbul, 2021, v. 8, n. 2, p. 196, doi. 10.14744/nci.2019.13281

By:

Yilmaz, Bugra;
Ozkaya, Ozan;
Islek, Ismail

Publication type:

Article

Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate.

Published in:

Modern Rheumatology, 2021, v. 31, n. 3, p. 733, doi. 10.1080/14397595.2020.1782592

By:

Gaku Miyamura;
Hiroki Wakabayashi;
Nobuto Nagao;
Sho Kato;
Taro Nakagawa;
Yohei Naito;
Akihiro Sudo

Publication type:

Article

Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK) in postmenopausal RA patients.

Published in:

Modern Rheumatology, 2013, v. 23, n. 3, p. 450, doi. 10.3109/s10165-012-0678-x

By:

Suzuki, Kouji;
Tsuji, Shigeyoshi;
Fukushima, Yaeko;
Nakase, Takanobu;
Hamada, Masayuki;
Tomita, Tetsuya;
Yoshikawa, Hideki

Publication type:

Article

Bilateral Simultaneous Atypical Femoral Fracture: A Case Report.

Published in:

Case Reports in Clinical Practice, 2022, v. 7, n. 2, p. 68

By:

Ghaffari, Salman;
Razavipour, Mehran;
Fateh, Soroosh

Publication type:

Article

Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2541, doi. 10.3390/jcm10122541

By:

Wu, Meng-Huang;
Lin, Yu-Sheng;
Wu, Christopher;
Lee, Ching-Yu;
Chen, Yi-Chia;
Huang, Tsung-Jen;
Cheng, Jur-Shan

Publication type:

Article

Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 932, doi. 10.3390/jcm8070932

By:

Hsu, Tsuen-Wei;
Hsu, Chien-Ning;
Wang, Shih-Wei;
Huang, Chiang-Chi;
Li, Lung-Chih

Publication type:

Article

Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 932, doi. 10.3390/jcm8070932

By:

Hsu, Tsuen-Wei;
Hsu, Chien-Ning;
Wang, Shih-Wei;
Huang, Chiang-Chi;
Li, Lung-Chih

Publication type:

Article

Bone Health and Denosumab Discontinuation in Oncology Populations.

Published in:

Oncologist, 2022, v. 27, n. 12, p. 998, doi. 10.1093/oncolo/oyac213

By:

Cheung, Yee-Ming Melody;
Morgans, Alicia;
Hamnvik, Ole-Petter Riksfjord

Publication type:

Article

EFFECTS OF SHORT TERM ALENDRONATE ADMINISTRATION ON BONE MINERAL DENSITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.

Published in:

Contributions / Prilozi (1857-9345), 2018, v. 39, n. 1, p. 5, doi. 10.2478/prilozi-2018-0019

By:

Aggarwal, H. K.;
Jain, Deepak;
Chhabra, Pulkit;
Yadav, R. K.

Publication type:

Article

Preparation and Biological Study of <sup>68</sup>Ga-DOTA-alendronate.

Published in:

Asia Oceania Journal of Nuclear Medicine & Biology, 2016, v. 4, n. 2, p. 98, doi. 10.7508/aojnmb.2016.02.006

By:

Fakhari, Ashraf;
Jalilian, Amir R.;
Johari-Daha, Fariba;
Shafiee-Ardestani, Mehdi;
Khalaj, Ali

Publication type:

Article

Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. 168, doi. 10.1080/21691401.2017.1416390

By:

Dong, Xue;
Zou, Shaohua;
Guo, Chunjing;
Wang, Kaili;
Zhao, Feng;
Fan, Huaying;
Yin, Jungang;
Chen, Daquan

Publication type:

Article

Alendronate delivery on amino modified mesoporous bioactive glass scaffolds to enhance bone regeneration in osteoporosis rats.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. 171, doi. 10.1080/21691401.2018.1453825

By:

Wang, Xiao;
Zeng, Deliang;
Weng, Weimin;
Huang, Qinfeng;
Zhang, Xiangkai;
Wen, Jin;
Wu, Jiannan;
Jiang, Xinquan

Publication type:

Article

Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 5, p. 519, doi. 10.1111/jcpt.12429

By:

Tan, W.;
Sun, J.;
Zhou, L.;
Li, Y.;
Wu, X.

Publication type:

Article

Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 4, p. 349, doi. 10.1111/jcpt.12149

By:

Patntirapong, S.;
Singhatanadgit, W.;
Arphavasin, S.

Publication type:

Article

Respiratory Paralysis in Sjogren's Syndrome: A Case Report.

Published in:

Apollo Medicine, 2023, v. 20, p. S96, doi. 10.4103/am.am_108_23

By:

Jain, Rachit;
Nath, Kshitiz;
Siddiqui, Zaki

Publication type:

Article

Availability and affordability of osteoporosis treatment drugs in Wuhan based on the WHO/HAI standard survey method.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 5, p. 417, doi. 10.5246/jcps.2023.05.035

By:

Min Wan;
Jinyu Liu;
Guangyi Yu;
Suiju Tong;
Lei Ke;
Yu Zhang;
Ruxu You

Publication type:

Article

Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review.

Published in:

Oral Diseases, 2023, v. 29, n. 1, p. 75, doi. 10.1111/odi.14003

By:

Martins, Lucio Henrique Ives;
Ferreira, Delaine Cristina;
Silva, Marcus Tolentino;
Motta, Rogério Heládio Lopes;
Franquez, Reginaldo Tavares;
Bergamaschi, Cristiane de Cássia

Publication type:

Article

Alteration of macrophage viability, differentiation, and function by bisphosphonates.

Published in:

Oral Diseases, 2018, v. 24, n. 7, p. 1294, doi. 10.1111/odi.12908

By:

Patntirapong, Somying;
Poolgesorn, Mahatana

Publication type:

Article

Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.

Published in:

Oral Diseases, 2017, v. 23, n. 4, p. 477, doi. 10.1111/odi.12632

By:

Fung, PPL;
Bedogni, G;
Bedogni, A;
Petrie, A;
Porter, S;
Campisi, G;
Bagan, J;
Fusco, V;
Saia, G;
Acham, S;
Musto, P;
Petrucci, MT;
Diz, P;
Colella, G;
Mignogna, MD;
Pentenero, M;
Arduino, P;
Lodi, G;
Maiorana, C;
Manfredi, M

Publication type:

Article

Effects of alendronate on the peri-implant bone in rats.

Published in:

Oral Diseases, 2015, v. 21, n. 2, p. 248, doi. 10.1111/odi.12258

By:

Oh, KC;
Moon, HS;
Lee, JH;
Park, YB;
Kim, J ‐ H

Publication type:

Article

Alendronate impairs epithelial adhesion, differentiation and proliferation in human oral mucosa.

Published in:

Oral Diseases, 2014, v. 20, n. 5, p. 466, doi. 10.1111/odi.12154

By:

Donetti, E;
Gualerzi, A;
Sardella, A;
Lodi, G;
Carrassi, A;
Sforza, C

Publication type:

Article

Long-term effectiveness of the combination of iguratimod and alendronate in SAPHO syndrome: a prospective cohort study.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 2842, doi. 10.1093/rheumatology/keae641

By:

Tang, Wangna;
Duan, Hongji;
Lv, Xueya;
Zhao, Hong;
Wu, Lingge;
Deng, Xiaoli

Publication type:

Article

How to use bisphosphonates safely and optimally.

Published in:

2018

By:

Jagpal, Aprajita;
Saag, Kenneth G

Publication type:

Editorial

Amgen and UCB announce increased cardiovascular risk in patients receiving romosozumab, an anti-sclerotin antibody.

Published in:: Rheumatology, 2017, v. 56, n. 8, p. e21, doi. 10.1093/rheumatology/kex244
Publication type:: Article

How does alendronate affect orthodontic tooth movement in osteogenesis imperfecta: an in vivo study on a mice model.

Published in:

European Journal of Orthodontics, 2023, v. 45, n. 2, p. 217, doi. 10.1093/ejo/cjad001

By:

Mehta, Shivam;
Wang, Ke;
Chen, Po-Jung;
Zhichao, Fan;
Ahmida, Ahmad;
Kalajzic, Zana;
Yadav, Sumit

Publication type:

Article

Role of flavonoids on oxidative stress and mineral contents in the retinoic acid-induced bone loss model of rat.

Published in:

European Journal of Nutrition, 2014, v. 53, n. 5, p. 1217, doi. 10.1007/s00394-013-0622-7

By:

Oršolić, Nada;
Goluža, Eleonora;
Đikić, Domagoj;
Lisičić, Duje;
Sašilo, Kristijan;
Rođak, Edi;
Jeleč, Želko;
Lazarus, Maja;
Orct, Tatjana

Publication type:

Article

Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.

Published in:

2006

By:

Bobba, Raja S.;
Beattie, Karen;
Parkinson, Bill;
Kumbhare, Dinesh;
Adachi, Jonathan D.

Publication type:

journal article

In vivo study of bovine hydroxyapatite-gelatin-hydroxypropyl methylcellulose with alendronate as injectable bone substitute composite in osteoporotic animal model.

Published in:

Journal of Advanced Pharmaceutical Technology & Research, 2022, v. 13, n. 4, p. 261, doi. 10.4103/japtr.japtr_266_22

By:

Budiatin, Aniek;
Gani, Maria;
Putri, Bulan;
Samirah, Samirah;
Hikmawati, Dyah;
Putra, Alfian;
Su'aidah, Nily;
Khotib, Junaidi

Publication type:

Article

Effect of Biphosphonate Treatment on Femur Head Avascular Necrosis.

Published in:

Journal of Physical Medicine & Rehabilitation Sciences, 2023, v. 26, n. 1, p. 508, doi. 10.31609/jpmrs.2022-91045

By:

KARAMAN, Nazlı;
ÜNLÜ, Zeliha

Publication type:

Article

The Result of Combination of Medical and Physical Therapy in Complex Regional Pain Syndrome.

Published in:

Journal of Physical Medicine & Rehabilitation Sciences, 2021, v. 24, n. 3, p. 251, doi. 10.31609/jpmrs.2021-81791

By:

YILMAZ, Ebru

Publication type:

Article

Renal Transplantlı Bir Hastada Steroid Kullanımına Bağlı Gelişen Multifokal Osteonekroz: Bir Olgu Sunumu.

Published in:

Journal of Physical Medicine & Rehabilitation Sciences, 2016, v. 19, n. 1, p. 66

By:

Coşkun Benlidayı, İlke;
Gökşen, Aylin;
Güzel, Rengin;
Sarpel, Tunay

Publication type:

Article

Effects of strontium ranelate on wear particle‑induced aseptic loosening in female ovariectomized mice.

Published in:

Molecular Medicine Reports, 2018, v. 18, n. 2, p. 1849, doi. 10.3892/mmr.2018.9133

By:

Geng, Tianxiang;
Chen, Xi;
Zheng, Mengxue;
Yu, Haochen;
Zhang, Shuai;
Sun, Shouxuan;
Guo, Haohui;
Jin, Qunhua

Publication type:

Article

Inhibition of farnesyl pyrophosphate synthase attenuates high glucose-induced vascular smooth muscle cells proliferation.

Published in:

Molecular Medicine Reports, 2017, v. 15, n. 5, p. 3153, doi. 10.3892/mmr.2017.6360

By:

GUO-PING CHEN;
XIAO-QIN ZHANG;
TAO WU;
JIE HAN;
DAN YE

Publication type:

Article

Alendronate, a double-edged sword acting in the mevalonate pathway.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 3, p. 4238, doi. 10.3892/mmr.2015.3957

By:

TRICARICO, PAOLA MAURA;
GIRARDELLI, MARTINA;
KLEINER, GIULIO;
KNOWLES, ALESSANDRA;
VALENCIC, ERICA;
CROVELLA, SERGIO;
MARCUZZI, ANNALISA

Publication type:

Article

Alendronate and fracture prevention.

Published in:

1999

By:

Cummings, S R;
Black, D;
Barrett-Connor, E;
Scott, J;
Wallace, R B

Publication type:

commentary

Alendronate and fracture prevention.

Published in:

1999

By:

Klovning, A;
Norheim, O F

Publication type:

commentary

Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy : A Propensity Score-Matched Cohort Study.

Published in:

2022

By:

Hayes, Kaleen N.;
Brown, Kevin A.;
Cheung, Angela M.;
Kim, Sandra A.;
Juurlink, David N.;
Cadarette, Suzanne M.

Publication type:

journal article

Alendronate treatment for osteogenesis imperfecta type III in twin babies: a case report.

Published in:

2013

By:

Moelyo, Annang Giri;
Widiretnani, Septin;
Suryandari, Ani

Publication type:

Abstract

Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.

Published in:

Cardiovascular Therapeutics, 2017, v. 35, n. 5, p. n/a, doi. 10.1111/1755-5922.12285

By:

Yang, Ying;
Rong, Xiqing;
Lv, Xue;
Jiang, Wenbing;
Yang, Yuan;
Lai, Dongwu;
Xu, Shiming;
Fu, Guosheng

Publication type:

Article

DEVELOPMENT AND OPTIMIZATION OF ALENDRONATE LOADED LIPOSOMES FOR ORAL ADMINISTRATION BY USING RESPONSE SURFACE METHODOLOGY.

Published in:

Studia Universitatis Vasile Goldis Seria Stiintele Vietii (Life Sciences Series), 2014, p. 73

By:

Ailiesei, Ioana;
Cinteza, Ludmila Otilia;
Orbesteanu, Ana Maria;
Cojocaru, Victor;
Anuta, Valentina

Publication type:

Article

Low-energy femoral shaft fracture in elderly patient with prolonged use of alendronate.

Published in:

Einstein (16794508), 2011, v. 9, n. 1, p. 1

By:

Vicente, José Ricardo Negreiros;
Rebolledo, Daniel Seguel;
Leonhardt, Marcos Camargo;
Bernstein, Mauricio

Publication type:

Article